Do you want to read an article? Please log in or register.
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
Macular DiseasesRetinal Diseases
Related content
COMMENTED
Macular Diseases
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Acta Ophthalmol
Gabrielle PH, Nguyen V, Bhandari S, Mehta H, Viola F, Arnold J, Fraser-Bell S, Barthelmes D, Creuzot-Garcher C, Gillies M
doi: 10.1111/aos.14672
COMMENTED
Macular Diseases
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1111/aos.14390.
COMMENTED
Macular Diseases
Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
Am J Ophthalmol.
Maggio E, Sartore M, Attanasio M, Maraone G, Guerriero M, Polito A, Pertile G
doi: 10.1016/j.ajo.2018.08.004.
Macular Diseases
Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol.
Glassman AR, Baker CW, Beaulieu WT, Bressler NM, Punjabi OS, Stockdale CR, Wykoff CC, Jampol LM, Sun JK, DRCR Retina Network
doi: 10.1001/jamaophthalmol.2019.6035.
COMMENTED
Macular Diseases
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial
JAMA.
Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK, DRCR Retina Network.
doi: 10.1001/jama.2019.5790.
Further Publications
Costs of Managing Diabetic Macular Edema with Good Visual Acuity with Aflibercept, Laser or Observation: DRCR Retina Network Protocol V
Am J Ophthalmol
Hutton DW, Glassman AR, Stein JD, Bressler NM, Sun JK, DRCR Retina Network.
doi: 10.1016/j.ajo.2021.02.033
COMMENTED
Macular Diseases
Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial
JAMA Ophthalmol.
Bressler NM, Odia I, Maguire M, Glassman AR, Jampol LM, MacCumber MW, Shah C, Rosberger D, Sun JK, DRCR Retina Network.
doi: 10.1001/jamaophthalmol.
Macular Diseases
Ranibizumab for the Treatment of Diabetic Macular Oedema in the Real-World Clinical Setting in Portugal: A Multicentre Study
Ophthalmologica.
Farinha C, Martins A, Neves A, Soares R, Ruão M, Ornelas M, Neves P, Gomes Rodrigues F, Coelho C, Silva R
doi: 10.1159/000489046.
COMMENTED
Macular Diseases
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)
doi: 10.1016/j.ophtha.2020.03.021.